Clinical trial

Simvastatin Addition for Patients With Recent-onset Schizophrenia

NCT01999309

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-10-01

PhasePHASE3

Study timeline

Study start (actual)2013-10-01Date precision: month

Registry last updated2020-10-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Schizoaffective Disorderunresolved

Schizophreniform Disorderunresolved

Psychosis NOSunresolved

Interventions

SimvastatinDRUG · verified · RxNorm: simvastatin

PlaceboDRUG

Sponsors & collaborators

Iris Sommerlead sponsor

Stanley Medical Research Institutecollaborator

Mapped research locations

GroningenNetherlands1 UtrechtNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01999309 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.